IRIS UniCatt

Deodato, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.898
EU - Europa 6.725
AS - Asia 6.289
SA - Sud America 1.085
AF - Africa 212
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 22.234
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.663
SG - Singapore 3.042
DE - Germania 2.509
CN - Cina 1.388
SE - Svezia 1.230
BR - Brasile 898
IT - Italia 619
FR - Francia 577
VN - Vietnam 565
UA - Ucraina 518
IN - India 313
GB - Regno Unito 311
IE - Irlanda 279
FI - Finlandia 219
ID - Indonesia 197
JP - Giappone 169
CA - Canada 137
HK - Hong Kong 118
RU - Federazione Russa 116
TR - Turchia 104
BD - Bangladesh 71
AR - Argentina 69
IQ - Iraq 58
NL - Olanda 56
MX - Messico 53
CI - Costa d'Avorio 50
BE - Belgio 49
ZA - Sudafrica 49
PL - Polonia 41
ES - Italia 34
IR - Iran 34
CZ - Repubblica Ceca 32
SA - Arabia Saudita 30
AT - Austria 29
EC - Ecuador 29
MA - Marocco 26
EG - Egitto 24
UZ - Uzbekistan 24
PH - Filippine 20
CL - Cile 19
PK - Pakistan 19
CO - Colombia 18
VE - Venezuela 17
KE - Kenya 16
LT - Lituania 16
TN - Tunisia 15
CH - Svizzera 14
KR - Corea 14
NP - Nepal 14
JM - Giamaica 13
RO - Romania 13
AU - Australia 12
JO - Giordania 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
BG - Bulgaria 11
UY - Uruguay 10
MY - Malesia 9
AZ - Azerbaigian 7
DZ - Algeria 7
IL - Israele 7
PE - Perù 7
RS - Serbia 7
SN - Senegal 7
AL - Albania 6
AM - Armenia 6
BO - Bolivia 6
DK - Danimarca 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LK - Sri Lanka 6
CR - Costa Rica 5
EU - Europa 5
GR - Grecia 5
HN - Honduras 5
LU - Lussemburgo 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
NI - Nicaragua 4
AO - Angola 3
BH - Bahrain 3
HR - Croazia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BS - Bahamas 2
EE - Estonia 2
KW - Kuwait 2
MK - Macedonia 2
MU - Mauritius 2
NG - Nigeria 2
Totale 22.202
Salva come PNG Salva come JPEG
Città #
Singapore 1.647
Chandler 1.233
Ashburn 752
San Jose 700
Beijing 326
Jacksonville 287
Dublin 276
San Mateo 258
The Dalles 210
Los Angeles 203
Lauterbourg 187
Ho Chi Minh City 186
Nanjing 180
Jakarta 172
Wilmington 171
New York 169
Dearborn 160
Hanoi 150
Boston 139
Tokyo 138
Bremen 125
Milan 122
Nürnberg 114
Frankfurt am Main 107
Munich 105
Woodbridge 104
Hong Kong 100
Marseille 98
São Paulo 97
Ann Arbor 96
Hefei 85
Lawrence 81
Cattolica 79
Helsinki 79
Rome 78
Princeton 77
Hyderabad 73
Izmir 69
Moscow 68
Dallas 67
Houston 66
Nanchang 65
Fairfield 60
Redwood City 55
Seattle 52
Abidjan 50
Brussels 49
Toronto 49
Orem 48
Chicago 47
Santa Clara 46
Buffalo 44
Guangzhou 36
Leawood 33
University Park 33
Zhengzhou 33
Augusta 32
Fremont 31
Kunming 31
Shenyang 31
Düsseldorf 30
Paris 30
Shanghai 30
London 29
Phoenixville 29
Norwalk 28
Redmond 28
Stockholm 28
Amsterdam 27
Montreal 27
Brooklyn 26
Hebei 26
St Louis 26
Tianjin 26
Turku 26
Warsaw 26
Da Nang 24
Lancaster 24
Mountain View 24
Boardman 23
Council Bluffs 23
Jiaxing 23
Lappeenranta 22
Pune 22
Rio de Janeiro 22
Changsha 21
Detroit 21
North York 21
Atlanta 20
Johannesburg 20
Mumbai 20
Nuremberg 20
Tashkent 20
Auburn Hills 19
Falls Church 19
Kent 19
Hangzhou 18
Mexico City 18
Cambridge 17
Phoenix 17
Totale 11.198
Salva come PNG Salva come JPEG
Nome #
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 296
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 226
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 224
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 216
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 210
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 200
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 191
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 191
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 188
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 187
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 187
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 187
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 186
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 185
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 184
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 182
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 182
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 181
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 180
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 174
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 174
In Vivo Portal Dosimetry by an Ionization Chamber 173
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 173
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 173
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 173
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 173
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 170
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 168
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 167
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 167
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 167
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 167
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 164
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 164
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 163
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 163
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 159
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 157
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 157
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 157
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 156
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 156
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 155
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 155
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 151
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 150
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 150
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 150
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 149
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 149
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 148
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 147
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 147
Real time transit dosimetry for the breath-hold radiotherapy technique experience 145
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 145
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 144
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 143
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study 140
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 140
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 139
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 139
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 138
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 138
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 138
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 137
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 137
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 136
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 135
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 135
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 135
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 134
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 133
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 133
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 133
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 131
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 130
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 130
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 130
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 130
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 129
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 128
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 128
Personalized Automation of Treatment Planning for Linac-Based Stereotactic Body Radiotherapy of Spine Cancer 127
Radiotherapy of prostate carcinoma: A comparison of the predictive role of EAU versus NCCN risk stratification systems 127
Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model 126
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 125
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 123
Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible? 123
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 123
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 122
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 120
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer 119
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 119
Clinical Studies on Ultrafractionated Chemoradiation: A Systematic Review 119
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 118
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 118
Advanced head and neck cancer in older adults: Results of a short course accelerated radiotherapy trial 118
Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial 117
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 116
Prognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription 115
Totale 15.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021260 0 0 0 0 0 0 0 0 0 70 155 35
2021/20221.513 139 87 21 107 119 51 25 224 58 116 283 283
2022/20233.480 472 477 243 584 207 404 189 277 394 41 144 48
2023/20241.424 66 422 57 110 38 158 92 118 13 44 193 113
2024/20253.078 73 80 208 112 348 76 58 154 527 357 593 492
2025/20267.679 1.229 228 404 757 1.492 485 1.394 508 662 520 0 0
Totale 22.529